Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug - Aurinia Pharmaceuticals

Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036

Aurinia Pharmaceuticals has struck a patent infringement settlement with Teva Pharmaceuticals, which should help stave off Teva's proposed generic to its lupus drug Lupkynis (voclosporin) in the Un | Aurinia…